AXDX News and Press, Accelerate Diagnostics Inc. From 03/29/23

2023-03-29 16:16:37 ET Accelerate Diagnostics press release ( NASDAQ: AXDX ): FY GAAP EPS of -$0.76 in-line. Revenue of $12.75M (+8.2% Y/Y) beats by $0.1M . Gross margin was 26% year-to-date, compared to an adjusted gross margin of 35% for the same period of the pr...

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire TUCSON, Ariz. , March 29, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended Dec...

2023-03-28 17:35:26 ET Major earnings expected after the bell on Wednesday include: RH ( RH ) Planet Labs ( PL ) Beam Global ( BEEM ) Semtech Corporation ( SMTC ) Other earnings slated for release after Wednesday's close include: AXDX , BC...

2023-03-28 17:35:20 ET Accelerate Diagnostics ( NASDAQ: AXDX ) is scheduled to announce Q4 earnings results on Wednesday, March 29th, after market close. The consensus EPS Estimate is -$0.14 and the consensus Revenue Estimate is $2.85M (-13.6% Y/Y). For further detai...

Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results PR Newswire TUCSON, Ariz. , March 15, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wedne...

Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors PR Newswire TUCSON, Ariz. , March 8, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) a disruptor in bloodstream infection identification and suscepti...

Accelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kit PR Newswire TUCSON, Ariz. , Dec. 19, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today ...

Summary Bionano Genomics, Inc. is an engaging company operating in the genome mapping space. The company generated $7.2m of revenues from 217 installed bases in Q322. Performance of genetic testing developers, e.g., Illumina and PacBio, in 2022 has been poor. Bionano is making b...

Accelerate Diagnostics, Inc. (AXDX) Q3 2022 Earnings Conference Call November 14, 2022, 16:30 ET Company Participants Laura Pierson - IR Officer Jack Phillips - CEO, President & Director Steve Reichling - CFO Conference Call Participants Andrew Br...

Accelerate Diagnostics press release ( NASDAQ: AXDX ): Q3 GAAP EPS of -$0.18. Revenue of $2.96M (-5.1% Y/Y). Gross margin was 26% for the quarter, compared to 32% in the second quarter of the prior year.  The decline in gross margins resulted from inflation to man...